J B Chemicals & Pharmaceuticals Stock Performance

as on July 16, 2026 at 9:31 pm IST

Day's Low
Day's High
₹2,380.00
Day's Price Range
₹2,525.50
₹2,408.90
1.20%
Downside
4.84%
Upside
52 Week's Low
52 Week's High
₹1,604.00
52-Week Price Range
₹2,525.50
₹2,408.90
33.41%
Downside
4.84%
Upside

J B Chemicals & Pharmaceuticals share price movements today

Previous Close: ₹2,506.00
Open: ₹2,506.00
Volume: 47.79L
Upper Circuit: ₹3,007.20
Lower Circuit: ₹2,004.80
Day's Low - High: ₹2,380.00 - ₹2,525.50
52 Week Low - High: ₹1,604.00 - ₹2,525.50

J B Chemicals & Pharmaceuticals Historical Returns

1 Month Return: -1.46 %
3 Month Return: + 9.04 %
1 Year Return: + 40.78 %
3 Year Return: + 77.7 %
5 Year Return: + 166.34 %

J B Chemicals & Pharmaceuticals Fundamentals

as on July 16, 2026 at 4:01 pm IST

Market Cap

₹38,676.99 Cr

Return on Equity (ROE)

18.18

PE Ratio (TTM)

Return on capital employed (ROCE)

24.24

Industry PE ratio

52.41

Beta (LTM)

P/B Ratio

8.2

Dividend Yield

1.07

PEG Ratio

Quarterly Earnings Growth YOY

-30.42

EPS (TTM)

44.19

Book Value

259.05

J B Chemicals & Pharmaceuticals Stock Valuation

as on July 16, 2026 at 4:01 pm IST

J B Chemicals & Pharmaceuticals in the last 5 years

Overview
Trends

Lowest (10.61x)

October 24, 2019

Industry (52.41x)

July 16, 2026

Today (53.22x)

July 16, 2026

Highest (62.92x)

February 7, 2024

LowHigh

Today’s Price to Earnings Ratio: 53.22x

J B Chemicals & Pharmaceuticals Technical Analysis

Track how J B Chemicals & Pharmaceuticals technical analysis has moved over time to understand its trends.

1 min

5 min

15 min

30 min

1 day

1 week

1 month

Technicals Summary

Bearish

Neutral

Bullish

Moving Averages

Bearish

Neutral

Bullish

Oscillators

Bearish

Neutral

Bullish

Overall

Bearish1

Bullish11

Neutral3

Oscillators

Name	Value	Action
MACD level (12,26)	4.66	Bullish
CCI (20)	327.15	Bearish
RSI (14)	64.98	Neutral
Momentum (10)	25.3	Bullish
ADI (14)	18.75	Neutral
Ultimate Oscillator (7,14,28)	50.42	Neutral

Moving Averages

Name	Value	Action
SMA (20)	2410.88	Bullish
EMA (20)	2412.8	Bullish
VWMA (20)	2413.49	Bullish
SMA (50)	2406.24	Bullish
EMA (50)	2409.63	Bullish
SMA (200)	2427.13	Bullish
EMA (200)	2425.28	Bullish
KAMA (200)	2408.14	Bullish
DEMA (200)	2401.3	Bullish

J B Chemicals & Pharmaceuticals Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of J B Chemicals & Pharmaceuticals with its industry peers.

Company	Analyst View	Market Cap(in ₹ Cr)	5 Year CAGR	Debt to Asset Ratio	Net Profit(in ₹ Cr)	Yearly Revenue(in ₹ Cr)
J B Chemicals & Pharmaceuticals Ltd	BUY	38,676.99	33.27%	0.50	709	4,147
Cohance Lifesciences Ltd	HOLD	17,052.93	-3.88%	0.68	264	1,197
Jubilant Pharmova Ltd	BUY	14,846.76	8.56%	0.71	397	8,279
Sun Pharma Advanced Research Company Ltd	NA	6,919.12	-4.99%	0.66	1,553	1,879
Rainbow Childrens Medicare Ltd	BUY	15,810.88	49.16%	0.68	281	1,703

See all

Market expectation of J B Chemicals & Pharmaceuticals Stock

Common consensus of the market based on various publicly available news, publications,brokerage expectation and market data

BUY

57.14%

Buy

42.86%

Hold

0.00%

Sell

J B Chemicals & Pharmaceuticals Ltd Quarterly Profit & Loss

Figures in Rupees Crores

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Sales	881.74	844.51	861.73	1,004.4	1,000.62	963.49	949.48	1,093.94	1,084.9	1,064.72	904.23
Other Income	7.66	7.35	16.63	5.89	9.95	8	14.48	14.55	15.34	18.28	11.98
Total Income	889.4	851.86	878.36	1,010.29	1,010.57	971.49	963.96	1,108.49	1,100.24	1,083	916.21
Expenses	638.2	621.39	663.61	724.03	730.1	708.98	723.04	793.07	775.3	768.9	730.28
Operating Profit	243.54	223.12	198.12	280.37	270.52	254.51	226.44	300.87	309.6	295.82	173.95
Operating Profit Margin %	27.62%	26.42%	22.99%	27.91%	27.04%	26.42%	23.85%	27.5%	28.54%	27.78%	19.24%
Profit Before Interest, Tax and Depreciation	251.2	230.47	214.75	286.26	280.47	262.51	240.92	315.42	324.94	314.1	185.93
Interest	10.37	12.49	9.41	5.64	2.06	2.58	1.45	1.11	1.35	1.88	1.23
Depreciation	32.17	34.03	40.74	40.78	41.88	41.94	46.44	42.7	44.44	45.35	50.01
Profit Before Tax	208.66	183.95	164.6	239.84	236.53	217.99	193.03	271.61	279.15	266.87	134.69
Tax Paid	58.07	50.38	38.44	63.01	61.96	55.5	47.34	69.23	71.33	68.98	33.32
Profit After Tax	150.59	133.57	126.16	176.83	174.57	162.49	145.69	202.38	207.82	197.89	101.37
Total Net profit including share of profit / Loss from associate company	150.59	133.57	126.16	176.83	174.57	162.49	145.69	202.38	207.82	197.89	101.37
EPS	9.72	8.62	8.22	11.39	11.24	10.46	9.36	12.99	13.29	12.63	6.35
Actual EPS	9.72	8.62	8.22	11.39	11.24	10.46	9.36	12.99	13.29	12.63	6.35
Adjusted EPS	9.72	8.62	8.22	11.39	11.24	10.46	9.36	12.99	13.29	12.63	6.35
Diluted EPS	9.54	8.46	8.06	11.16	11	10.24	9.17	12.75	13.08	12.45	6.32

J B Chemicals & Pharmaceuticals Ltd Annual Profit & Loss

Figures in Rupees Crores

	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Sales	1,412.98	1,643.2	1,774.73	2,042.52	2,424.24	3,149.28	3,484.18	3,917.99	4,147.79
Other Income	37.11	41.44	50.67	112.38	39.23	9.94	37.27	38.32	60.15
Total Income	1,450.09	1,684.64	1,825.4	2,154.9	2,463.47	3,159.22	3,521.45	3,956.31	4,207.94
Expenses	1,195.67	1,337.36	1,407.15	1,482.11	1,880.79	2,453.53	2,587.29	2,886.15	3,067.54
Operating Profit	217.31	305.84	367.58	560.41	543.45	695.75	896.89	1,031.84	1,080.25
Operating Profit Margin %	15.38%	18.61%	20.71%	27.44%	22.42%	22.09%	25.74%	26.34%	26.04%
Profit Before Interest, Tax and Depreciation	254.42	347.28	418.24	672.79	582.68	705.69	934.16	1,070.16	1,140.4
Interest	3.49	4.65	3.03	7.24	5.12	36.05	44.33	11.73	5.57
Depreciation	56.97	55.64	66.32	68.67	72.66	114.41	138.32	171.04	182.5
Profit Before Tax	193.96	286.99	348.89	596.88	504.9	555.23	751.51	887.39	952.33
Tax Paid	55.23	93.02	76.5	148.36	118.86	145.23	198.88	227.81	242.86
Profit After Tax	138.72	193.97	272.39	448.52	386.04	410	552.63	659.58	709.47
Total Net profit including share of profit / Loss from associate company	138.72	193.97	272.39	448.52	386.04	410	552.63	659.58	709.47
EPS	16.48	23.54	34.2	57.96	49.86	53	35.66	42.45	45.16
Actual EPS	16.48	23.54	34.2	57.96	49.86	53	35.66	42.45	45.16
Adjusted EPS	8.24	11.77	17.1	28.98	24.93	26.5	35.66	42.45	45.16
Diluted EPS	16.48	23.54	34.2	57.96	49.86	52.34	34.85	41.56	44.45

J B Chemicals & Pharmaceuticals Ltd Cash Flow

Figures in Rupees Crores

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Net Cash from Operating Activities	140.41	201.13	122.92	194.33	275.75	314.78	170.13	625.61	800.61	902.45	703.92
Cash Flow from Investing Activities	-25.91	-45.31	-20.68	-27.69	23.91	-230.63	2.33	-961.77	-403.85	-295.9	-585.73
Cash Flow from Financing Activities	-99.62	-183.84	-59.53	-155.74	-306.06	-87.43	-138.39	362.12	-385.49	-579.68	-123.09
Net Cash Flow	14.88	-28.02	42.72	10.9	-6.39	-3.28	34.07	20.39	11.28	26.88	-4.91

J B Chemicals & Pharmaceuticals Stock Shareholding Pattern

Numbers in percentages

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Jan 2026	Mar 2026
Promoters	53.86%	53.83%	53.78%	53.77%	53.74%	53.66%	47.84%	47.73%	47.56%	47.55%	48.78%	48.8%
DII	18.58%	17.97%	18.38%	17.62%	16.81%	16.41%	18.72%	19.63%	22.83%	23.36%	22.71%	21.38%
FII	10.05%	0%	11.06%	12.17%	13.63%	14.64%	18.3%	17.77%	15.3%	14.88%	14.56%	16.33%
Government	0%	0%	0.01%	0%	0.01%	0%	0%	0%	0%	0%	0%	0%
Public	17.51%	17.28%	16.78%	16.43%	15.81%	15.29%	15.14%	14.88%	14.3%	14.21%	13.95%	13.48%
Total Outstanding Shares	15,49,55,510	15,50,44,160	15,51,94,800	15,52,13,058	15,53,14,408	15,55,48,728	15,56,77,208	15,60,58,924	15,65,96,239	15,66,50,956	16,04,35,056	16,05,58,706
Total Shareholders	60,817	63,230	63,892	66,953	62,743	62,081	63,948	70,064	71,957	69,338	68,966	74,043

Insights on J B Chemicals & Pharmaceuticals Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Promoter Holding Up
Promoters have increased holdings from 48.78% to 48.80% in Mar 2026 quarter
POSITIVE IMPACT
Price Rise
In the last 1 month, JBCHEPHARM stock has moved up by 14.3%
POSITIVE IMPACT
FII Holding Up
Foreign Institutions have increased holdings from 14.56% to 16.33% in Mar 2026 quarter
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 3 quarters, 207.82 Cr → 101.37 Cr (in ₹), with an average decrease of 26.8% per quarter
NEGATIVE IMPACT
Retail Holding Down
Retail Investor have decreased holdings from 13.95% to 13.48% in Mar 2026 quarter
NEGATIVE IMPACT
MF Holding Down
Mutual Funds have decreased holdings from 19.22% to 19.00% in Mar 2026 quarter
NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 4 quarters, 1.10K Cr → 916.21 Cr (in ₹), with an average decrease of 5.9% per quarter

About J B Chemicals & Pharmaceuticals Ltd

J B Chemicals Pharmaceuticals, founded in 1976 in Maharastra, is a global player in pharmaceutical manufacturing. It manufactures and markets a wide range of pharmaceutical formulations, herbal remedies, APIs, and agro-based products. It has subsidiaries in India and other countries and has been awarded the Certificate of Suitability to European Pharmacopoeia Monograph for Nifedipine EP from the European Directorate for Quality Medicines. It launched new products in the global market to expand its product portfolio and received approval from TGA Australia, USFDA, MCC South Africa, INVIMA Colombia, and MHRA UK. The company received the 'Most Trustworthy European Brand' by Readers Digest in cold and cough segment for the fourth consecutive year in 2003-04. It diverted into the contrast media products market during 2004-05 and entered agreements with PharmaaCare Pharmaceuticals and Ranbaxy Group for developing and marketing niche products in respective markets. It has undergone several mergers and diversifications in-order to increase its product range and profitability. More recently, it acquired a portfolio of brands from Sanzyme Private Limited and Azmarda brand from Novartis AG Switzerland. Thus, J B Chemicals Pharmaceuticals is well positioned to grow and progress further in the global pharmaceutical market.

Revenue: ₹904.23Cr as on March 2026 (Q4 FY26)
Net Profit: ₹101.37Cr as on March 2026 (Q4 FY26)
Listing date: 02 Feb, 1995
Chairperson Name: Ranjit Shahani.

Organisation	J B Chemicals & Pharmaceuticals Ltd
Headquarters	Mumbai
Industry	Pharmaceuticals
CEO	Ranjit Shahani.
E-voting on shares	Click here to vote

FAQs

What is J B Chemicals & Pharmaceuticals share price today?

J B Chemicals & Pharmaceuticals share price today stands at ₹2408.9 as on July 16, 2026 at 4:01 pm IST at the close of the market. J B Chemicals & Pharmaceuticals share today touched a day high of ₹2525.5 and a low of ₹2380.

What is the 52 week high and 52 week low range for J B Chemicals & Pharmaceuticals share?

J B Chemicals & Pharmaceuticals touched a 52 week high of ₹2525.5 and a 52 week low of ₹1604. J B Chemicals & Pharmaceuticals share price today i.e. July 16, 2026 at 4:01 pm IST is closed at ₹2408.9, which is -4.62% down from its 52 week high and 50.18% up from its 52 week low.

What is J B Chemicals & Pharmaceuticals's market capitalisation today?

J B Chemicals & Pharmaceuticals market capitalisation is ₹38,676.99 Cr as on July 16, 2026 at 4:01 pm IST.

How to buy J B Chemicals & Pharmaceuticals shares?

To buy J B Chemicals & Pharmaceuticals shares, you need to follow these steps:

Open a Demat account and Trading account on INDmoney
Fund your Trading account
Search for JBCHEPHARM or J B Chemicals & Pharmaceuticals Ltd on the INDmoney app to check live prices of the stock
Click on Buy or SIP to place an order to invest in J B Chemicals & Pharmaceuticals shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is J B Chemicals & Pharmaceuticals trading volume today?

J B Chemicals & Pharmaceuticals trading volume is 47.79L as on July 16, 2026 at 4:01 pm IST. This means that 47.79L shares of J B Chemicals & Pharmaceuticals were bought and sold on the stock market during today's trading session.